Intellia Therapeutics (NTLA) EBITDA Margin (QoQ) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Intellia Therapeutics 1.63 Bn 1.63 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -23,198.00
Dec 31, 2025 31,677.00
Sep 30, 2025 -1,910.00
Jun 30, 2025 -2,875.00
Mar 31, 2025 33,725.00
Dec 31, 2024 41,854.00
Sep 30, 2024 67,493.00
Jun 30, 2024 -174,147.00
Mar 31, 2024 -719,975.00
Dec 31, 2023 784,236.00
Sep 30, 2023 -9,817.00
Jun 30, 2023 -13,845.00
Mar 31, 2023 4,136.00
Dec 31, 2022 3,064.00
Sep 30, 2022 -12,390.00
Jun 30, 2022 62,533.00
Mar 31, 2022 -70,243.00
Dec 31, 2021 2.33 Mn
Sep 30, 2021 -2.29 Mn
Jun 30, 2021 -33,337.00
Mar 31, 2021 -7,690.00
Dec 31, 2020 -51,436.00
Sep 30, 2020 7,467.00
Jun 30, 2020 43,336.00
Mar 31, 2020 -37,464.00
Dec 31, 2019 -3,738.00
Sep 30, 2019 738.00
Jun 30, 2019 -1,978.00
Mar 31, 2019 3,285.00
Dec 31, 2018 6,414.00
Sep 30, 2018 -1,703.00
Jun 30, 2018 -349.00
Mar 31, 2018 8,472.00
Dec 31, 2017 -15,369.00
Sep 30, 2017 5,373.00
Jun 30, 2017 -6,236.00
Mar 31, 2017 -1,601.00
Dec 31, 2016 -3,424.00
Sep 30, 2016 706.00
Jun 30, 2016 21,156.00
Mar 31, 2016 -5,237.00
Dec 31, 2015 -12,878.00
Sep 30, 2015 5,295.00
Jun 30, 2015 -15,559.00